John R. Lewandowski (Founder/CEO) is a PhD student at MIT in the Mechanosynthesis Group underneath Prof. John Hart, focusing on low-cost diagnostics leveraging the physics of microparticles, optics, magnetism, and self assembly. He is also the Founder of Disease Diagnostic Group, a medical device company focusing on low-cost disease diagnostics using magneto-optical technology.

Lewandowski's interest in disease diagnostics goes back all the way to high school, where he was a two-time state champion in Disease Detectives in Science Olympiad. He graduated in 2012 from Case Western Reserve University with bachelor’s degrees in mechanical engineering, entrepreneurship, economics, and business management, continuing on with a Masters of Engineering and Management degree from CWRU. He has experience in medical device design and commercialization with internships at Cleveland Clinic, General Electric, CWRU, as well as a drug-delivery start-up Recon Therapeutics. He’s also been Managing Partner at Lew & Dowski Capital, LLC for the past four years, scaling a boutique investment fund based on an innovative supply and demand model in a niche market with a quickly growing NAV of $500,000. He has been recognized as a National Defense Science and Engineering Graduate Fellow, a NSF Graduate Research Fellow, a Hertz Foundation Fellowship Finalist, a Tata Fellow, a Don Richards Fellow, a Tau Beta Pi Fellow, a member of Phi Beta Kappa Society, a Forbes 30 under 30 nominee, distinguished in Think Magazine’s 30 under Thirty and Foreign Policy’s 100 Leading Thinkers, and a Lemelson-MIT Prize Inventor. He’s been an author on a dozen papers and holds one patent on drug reconstitution.

Health, Engineering, Researcher